title: Emerging therapy for adrenocortical carcinoma.
abstract: Adrenocortical carcinoma (ACC) is a very rare and aggressive tumor with dismal outcomes. Best current treatments include complete surgical resection for localized resectable disease and systemic therapy with mitotane alone or in combination for advanced ACC. Advances in molecular genetic profiling of ACC have created multiple new targets for potential treatment options in ACC. This article reviews the current treatment options available for ACC and discusses the potential new targets identified through molecular profiling.
authors: Endocrine Oncology Branch, National Cancer Institute, NIH, Bethesda, MD, USA.
authors: Rachel D
authors: RD
authors: Aufforth
authors: Endocrine Oncology Branch, National Cancer Institute, NIH, Bethesda, MD, USA.
authors: Naris
authors: N
authors: Nilubol
keywords: adrenocortical carcinoma; genomics; molecular profiling; systemic treatment
references: Endocr Relat Cancer. 2011 Feb 23;18(2):R15-27
references: 21208995
references: Eur J Cancer. 2006 May;42(8):1040-3
references: 16574405
references: Endocr Pract. 2010 May-Jun;16(3):441-5
references: 20061282
references: Endocr Relat Cancer. 2005 Sep;12(3):657-66
references: 16172198
references: N Engl J Med. 1990 Apr 26;322(17):1195-201
references: 2325710
references: J Mol Endocrinol. 2005 Oct;35(2):245-56
references: 16216906
references: Exp Cell Res. 2011 Jun 10;317(10):1397-410
references: 21376716
references: PLoS One. 2013;8(3):e58725
references: 23527013
references: J Clin Endocrinol Metab. 2006 Jul;91(7):2650-5
references: 16670169
references: Invest New Drugs. 2013 Dec;31(6):1505-13
references: 23982248
references: Cancer Res. 2005 Sep 1;65(17):7622-7
references: 16140927
references: Jpn J Clin Oncol. 2009 Mar;39(3):183-5
references: 19168875
references: Genes Dev. 2004 Aug 15;18(16):1926-45
references: 15314020
references: Cancer. 2011 Apr 15;117(8):1630-9
references: 21472710
references: J Clin Endocrinol Metab. 2009 Jan;94(1):204-12
references: 18854392
references: Clin Cancer Res. 2011 Sep 15;17(18):6052-60
references: 21750201
references: J Clin Endocrinol Metab. 2013 Oct;98(10):4080-8
references: 23979958
references: J Clin Endocrinol Metab. 2009 Jun;94(6):2178-83
references: 19318454
references: Endocr Relat Cancer. 2010 Feb 18;17(1):265-72
references: 20026647
references: Eur J Endocrinol. 1997 Mar;136(3):296-303
references: 9100555
references: Mod Pathol. 2010 Dec;23(12):1596-604
references: 20693985
references: Endocr Pathol. 2009 Spring;20(1):17-23
references: 19184558
references: Endocr Relat Cancer. 2010 Feb 18;17(1):169-77
references: 19955217
references: Mod Pathol. 1994 Sep;7(7):741-6
references: 7824507
references: Endocr Relat Cancer. 2013 Jul 05;20(4):579-94
references: 23756429
references: J Clin Endocrinol Metab. 2002 Nov;87(11):4961-5
references: 12414859
references: J Clin Endocrinol Metab. 2010 Oct;95(10):E161-71
references: 20660055
references: Clin Cancer Res. 2009 Nov 15;15(22):7061-8
references: 19903778
references: Mol Endocrinol. 2007 Dec;21(12):2968-87
references: 17761949
references: J Clin Endocrinol Metab. 2008 Aug;93(8):3222-5
references: 18544621
references: Nat Rev Drug Discov. 2009 Aug;8(8):627-44
references: 19644473
references: Virchows Arch. 2008 Feb;452(2):181-91
references: 18157729
references: J Clin Endocrinol Metab. 2013 Jan;98(1):161-71
references: 23162091
references: Ann Surg Oncol. 1999 Dec;6(8):719-26
references: 10622498
references: J Steroid Biochem Mol Biol. 2014 Mar;140:26-33
references: 24269839
references: J Clin Endocrinol Metab. 2006 Jun;91(6):2027-37
references: 16551738
references: PPAR Res. 2008;2008:904041
references: 18670617
references: Endocr Rev. 2009 May;30(3):241-63
references: 19403887
references: J Clin Endocrinol Metab. 2012 Dec;97(12):E2238-50
references: 23074235
references: Cancer Res. 2001 Sep 15;61(18):6762-7
references: 11559548
references: Cancer Res. 2010 Jun 1;70(11):4666-75
references: 20484036
references: J Clin Endocrinol Metab. 2008 Jun;93(6):2057-62
references: 18334586
references: Endocrine. 2012 Dec;42(3):521-5
references: 22706605
references: Am J Pathol. 2003 Feb;162(2):521-31
references: 12547710
references: Hum Mol Genet. 2010 Apr 15;19(8):1561-76
references: 20106872
references: N Engl J Med. 2012 Jun 7;366(23):2189-97
references: 22551107
references: J Clin Endocrinol Metab. 2005 Jul;90(7):3886-96
references: 15886257
references: Eur J Endocrinol. 2006 Apr;154(4):587-98
references: 16556722
references: Ann Oncol. 2000 Oct;11(10):1281-7
references: 11106117
references: Surgery. 2007 Dec;142(6):867-75; discussion 867-75
references: 18063070
references: Cancer Res. 2009 Oct 1;69(19):7662-71
references: 19789339
references: Br J Cancer. 2013 Mar 5;108(4):826-30
references: 23412108
references: J Clin Endocrinol Metab. 2012 Oct;97(10 ):3495-503
references: 22837187
references: Cancer. 2009 Jan 15;115(2):243-50
references: 19025987
references: Ann Thorac Surg. 2011 Dec;92(6):1965-70
references: 22000277
references: Clin Cancer Res. 2011 Jan 15;17(2):328-36
references: 21088256
references: J Clin Endocrinol Metab. 2013 Dec;98(12):4759-67
references: 24057287
references: Hum Pathol. 1990 Mar;21(3):277-82
references: 2312105
references: Cancer Ther. 2008;6(A):25-34
references: 19079765
references: Clin Endocrinol (Oxf). 2011 Nov;75(5):585-91
references: 21883349
references: J Clin Endocrinol Metab. 2014 Feb;99(2):455-61
references: 24302750
references: N Engl J Med. 2007 Jun 7;356(23):2372-80
references: 17554118
references: J Clin Endocrinol Metab. 2013 Jan;98(1):181-91
references: 23150691
references: J Clin Endocrinol Metab. 2000 Dec;85(12):4734-41
references: 11134136
references: Eur J Endocrinol. 1995 Aug;133(2):133-44
references: 7655635
references: Eur J Endocrinol. 2012 Mar;166(3):451-8
references: 22189997
references: Endocr Relat Cancer. 2009 Sep;16(3):895-906
references: 19546168
references: Cancer Chemother Pharmacol. 2010 Mar;65(4):765-73
references: 19649631
references: Eur J Endocrinol. 2014 Feb 04;170(3):385-91
references: 24347427
references: J Surg Oncol. 2012 Jun 1;105(7):709-13
references: 22189845
references: Curr Med Chem. 2007;14(17):1893-910
references: 17627525
references: Clin Cancer Res. 2009 Jan 15;15(2):668-76
references: 19147773
references: Cancer Res. 2007 Jan 15;67(2):600-8
references: 17234769
references: Eur J Endocrinol. 2010 Feb;162(2):349-56
references: 19903796
references: Mol Cell Endocrinol. 2012 Mar 31;351(1):111-7
references: 22056416
references: Ann Surg Oncol. 2012 Aug;19(8):2643-51
references: 22526905
references: Cell Immunol. 2012 Oct;279(2):160-6
references: 23246677
references: J Clin Endocrinol Metab. 2010 Nov;95(11):4925-32
references: 20668036
references: Cancer Res. 2006 Feb 1;66(3):1500-8
references: 16452206
references: Clin Cancer Res. 2009 Dec 15;15(24):7684-7692
references: 19996210
references: J Clin Endocrinol Metab. 2005 Mar;90(3):1332-9
references: 15585569
references: Endocr Relat Cancer. 2011 Oct 27;18(6):643-55
references: 21859927
references: N Engl J Med. 2007 Sep 20;357(12):1256-7; author reply 1259
references: 17881760
references: J Clin Endocrinol Metab. 2013 Dec;98(12):4551-64
references: 24081734
references: Cancer. 2001 Sep 15;92(6):1385-92
references: 11745214
references: Br J Cancer. 1994 May;69(5):947-51
references: 8180029
references: Ann Thorac Surg. 2011 Oct;92(4):1195-200
references: 21958764
references: Nat Rev Endocrinol. 2014 Apr;10(4):215-28
references: 24492180
references: Ann Surg Oncol. 2010 Jan;17(1):263-70
references: 19851811
references: J Clin Oncol. 2009 Mar 1;27(7):1108-15
references: 19139432
references: Surgery. 2005 Dec;138(6):1087-94
references: 16360395
references: Oncogene. 2007 Mar 22;26(13):1932-40
references: 17001314